Advertisement Terumo launches new Azur system with hydrogel technology - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Terumo launches new Azur system with hydrogel technology

Terumo Interventional Systems has launched the Azur Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations, and aneurysms.

Azur is claimed to be the only peripheral platinum coil embolization system with a hydrogel coating that expands when introduced into the bloodstream, delivering greater filling and mechanical occlusion all with fewer coils. Azur’s hydrogel coating undergoes limited expansion within the first three minutes, and fully expands within 20 minutes. The result is greater filling and mechanical stability with fewer coils.

Fernando Yuste, marketing manager of interventional products for Terumo Interventional Systems, said: “With the initial feedback that we’ve received from physicians, we’re predicting that Azur will be the new gold standard for endovascular occlusion of vascular lesions.”